PREEMIEr Diagnostics

United States Founded: 2020 • Age: 6 yrs
Developer of a device to measure the blood glucose level in premature infants
Annual revenue - Latest available
Total funding - 1 rounds
Employees - Tracked headcount
Investors 1 Known backers
Products 1 Services tracked
Competitors 11 Brand Intelligence

About PREEMIEr Diagnostics

PREEMIEr Diagnostics is a company based in United States founded in 2020 by Tammy Movsas Movsas. PREEMIEr Diagnostics offers products and services including Infant Diagnostics. PREEMIEr Diagnostics operates in a competitive market with competitors including Dexcom, Livongo, Cordlife, Bigfoot Biomedical and Senseonics, among others.

  • Headquarter United States
  • Founders Tammy Movsas Movsas
  • Sectors
    Healthcare
    Technology
  • Phone
    Locked
  • Website
    Locked
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Technology → Extended, Virtual & Augmented Reality Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    $25 K (USD), Grant

    Jun 02, 2020

  • Investors
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of PREEMIEr Diagnostics

PREEMIEr Diagnostics offers a comprehensive portfolio of products and services, including Infant Diagnostics.

Product name locked
Category locked
Primary

Provides solutions to monitor and improve health of premature infants.

Funding Insights of PREEMIEr Diagnostics

Investors in PREEMIEr Diagnostics

PREEMIEr Diagnostics has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include MassChallenge.

All
Venture Fund
Investor Description Founded Year Domain Location
Early-stage entrepreneurs are accelerated through MassChallenge's program.
Locked Locked Locked
Premium access

Investor details for PREEMIEr Diagnostics

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by PREEMIEr Diagnostics

Investments
Premium access

Investment portfolio details for PREEMIEr Diagnostics

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - PREEMIEr Diagnostics

Premium access

Detailed financials for PREEMIEr Diagnostics

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Preemier Diagnostics Comparisons

PREEMIEr Diagnostics Primary company
Description
Developer of a device to measure the blood glucose level in ...
Location
United States
Founded Year
2020
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for PREEMIEr Diagnostics

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of PREEMIEr Diagnostics

PREEMIEr Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Dexcom, Livongo, Cordlife, Bigfoot Biomedical and Senseonics, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Wearable glucose monitoring patches are provided for real-time data tracking.
Locked Locked Locked
Provider of smart devices for diabetes management for patients and doctors
Locked Locked Locked
Cordlife is engaged in cord blood banking and diagnostics.
Locked Locked Locked
Developer of a closed-loop automated insulin delivery system
Locked Locked Locked
Implantable continuous glucose monitoring systems are provided for diabetes management.
Locked Locked Locked
Provider of workforce healthcare solutions
Premium access

Detailed competitors of PREEMIEr Diagnostics

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Preemier Diagnostics

Premium access

Complete news archive for PREEMIEr Diagnostics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about PREEMIEr Diagnostics

PREEMIEr Diagnostics was founded in 2020.

PREEMIEr Diagnostics is headquartered in United States.

PREEMIEr Diagnostics was founded in 2020 in the United States. The company operates in the neonatal health sector, where a specialized device is developed to measure blood glucose levels in premature infants. This tool is used to identify infants requiring glucose adjustments and to detect early signs of disease onset. Operations focus on device innovation for improved infant care in clinical settings.

PREEMIEr Diagnostics's top competitors include Dexcom, Senseonics and Cordlife.

PREEMIEr Diagnostics offers Infant Diagnostics.

PREEMIEr Diagnostics has 1 investor. Key investors include MassChallenge.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available